A patient with chronic hepatitis D was successfully treated with a short course of peginterferon (PEG IFN)- -2a

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1504, 2005-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PEG IFN- -2a flies ahead in chronic hepatitis C

Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A 23% market share of new prescriptions for hepatitis C in the US has been captured by Roche's antiviral agent PEG-interferon (IFN)- -2a

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 402, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

PEG IFN- -2a improves QOL in hepatitis C

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

PEG IFN- -2b plus ribavirin worth its cost in chronic hepatitis C

Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2b: Autoimmune hepatitis in a patient with chronic hepatitis C virus and HIV infections: case report

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite